Table 1.
Patient characterization
| Age | 61 [54/69] |
| Gender (female/male) | 14 (70 %)/6 (30 %) |
| BMI (kg/m2) | 23 [22/26] |
| Diagnosis leading to ICU stay | |
| ARDS (ECMO, ECLA) | 6 (30 %) |
| ARDS (without ECMO, ECLA) | 8 (40 %) |
| Mediastinitis | 1 (5 %) |
| Peritonitis | 3 (15 %) |
| Intracranial hemorrhage | 1 (5 %) |
| Polytrauma | 1 (5 %) |
| At least one event of SIRS or sepsis during CGM | 20 (100 %) |
| Sequential organ failure assessment (SOFA) Score at inclusion | 8 [4/10] |
| Acute physiology and chronic health evaluation (APACHE) 2 Score at admission | 24 [19/28] |
| History of diabetes mellitus | 5 (25 %) |
| Administration of intravenous insulin therapy during CGM | 14 (70 %) |
| Administration of vasopressors during CGM | 7 (35 %) |
| Mean dose of epinephrine during sensor running time (µg/kg/min) (in seven patients receiving vasopressors) | 0.08 [0.03/0.14] |
| Mortality during ICU stay | 4 (20 %) |
n = 20 patients
Results are expressed as median with interquartile range or as absolute numbers with percentages of n = 20 patients
BMI body mass index, ARDS acute respiratory distress syndrome, ECMO extracorporeal membrane oxygenation, ECLA extracorporeal lung assist, SIRS systemic inflammatory response syndrome, SOFA sequential organ failure assessment, APACHE acute physiology and chronic health evaluation, ICU intensive care unit, CGM continuous glucose monitoring